Strengths and considerations
No source-reviewed explanatory claims are recorded here yet.
ESM Only as evaluated in the cited study. Paper-specific evaluated pipeline; exact checkpoint not inferred from label
Key specifications have not been extracted for this record. See the linked evaluation and sources for the reported setup.
limited source coverage · Automated source review, 2026-09-17. All specifications and missing details
1 evaluation · 7 results. Different protocols are not a single leaderboard.
Applied filters: All linked evaluations
| Tested configuration | Protocol and dataset | Finding | Evidence and details |
|---|---|---|---|
| Configuration: ESM Only | Protocol: Protective-antigen classification feature comparison (vaccine-antigen candidate prediction) Dataset: Protective-antigen classification feature comparison | 0.85 ± 0.036 AUPRC fraction · higher Uncertainty: type: reported_plus_minus_type_unresolved; value: 0.036 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceESM Only: Protective-antigen classification feature comparison Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples. Aggregation: Not reported Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row ESM Only, column AUPRC; XML row3 column7 |
| Configuration: ESM Only | Protocol: Protective-antigen classification feature comparison (vaccine-antigen candidate prediction) Dataset: Protective-antigen classification feature comparison | 0.98 ± 0.004 Specificity fraction · higher Uncertainty: type: reported_plus_minus_type_unresolved; value: 0.004 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceESM Only: Protective-antigen classification feature comparison Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples. Aggregation: Not reported Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row ESM Only, column Specificity; XML row3 column4 |
| Configuration: ESM Only | Protocol: Protective-antigen classification feature comparison (vaccine-antigen candidate prediction) Dataset: Protective-antigen classification feature comparison | 0.75 ± 0.063 Sensitivity fraction · higher Uncertainty: type: reported_plus_minus_type_unresolved; value: 0.063 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceESM Only: Protective-antigen classification feature comparison Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples. Aggregation: Not reported Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row ESM Only, column Sensitivity; XML row3 column3 |
| Configuration: ESM Only | Protocol: Protective-antigen classification feature comparison (vaccine-antigen candidate prediction) Dataset: Protective-antigen classification feature comparison | 0.96 ± 0.005 Val Accuracy fraction · higher Uncertainty: type: reported_plus_minus_type_unresolved; value: 0.005 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceESM Only: Protective-antigen classification feature comparison Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples. Aggregation: Not reported Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row ESM Only, column Val Accuracy; XML row3 column2 |
| Configuration: ESM Only | Protocol: Protective-antigen classification feature comparison (vaccine-antigen candidate prediction) Dataset: Protective-antigen classification feature comparison | 0.77 ± 0.043 MCC dimensionless · higher Uncertainty: type: reported_plus_minus_type_unresolved; value: 0.043 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceESM Only: Protective-antigen classification feature comparison Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples. Aggregation: Not reported Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row ESM Only, column MCC; XML row3 column6 |
| Configuration: ESM Only | Protocol: Protective-antigen classification feature comparison (vaccine-antigen candidate prediction) Dataset: Protective-antigen classification feature comparison | 0.94 AUROC fraction · higher Uncertainty: Not reported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceESM Only: Protective-antigen classification feature comparison Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples. Aggregation: Not reported Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row ESM Only, column AUROC; XML row3 column8 |
| Configuration: ESM Only | Protocol: Protective-antigen classification feature comparison (vaccine-antigen candidate prediction) Dataset: Protective-antigen classification feature comparison | 0.96 ± 0.007 Weighted F1 fraction · higher Uncertainty: type: reported_plus_minus_type_unresolved; value: 0.007 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceESM Only: Protective-antigen classification feature comparison Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples. Aggregation: Not reported Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row ESM Only, column Weighted F1; XML row3 column5 |
Source checking is not independent reproduction. Release 2026-09-29-06401fd5b220.
Paper-specific evaluated pipeline; exact checkpoint not inferred from label
No source-reviewed explanatory claims are recorded here yet.
No source-reviewed explanatory claims are recorded here yet.
Primary-source transcription and separate automated review. No human sign-off or experimental reproduction.
Stable record: paper-model-d637ae639d81cd6303Explanatory profile: limited source coverage · Automated source review, 2026-09-17. Review applies to the cited claims; unresolved fields are listed below. Numerical results retain their own review status.
| Property | Description and evidence |
|---|---|
| Model type | Not extracted or verified for this record. |
| Inputs | Not extracted or verified for this record. |
| Outputs | Not extracted or verified for this record. |
| Parameters | Not extracted or verified for this record. |
| Known versions | Not extracted or verified for this record. |
| Training data | Not extracted or verified for this record. |
| Context limits | Not extracted or verified for this record. |
| Access | Not extracted or verified for this record. |
| Code licence | Not extracted or verified for this record. |
| Weights licence | Not extracted or verified for this record. |
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
2 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|---|---|
| Evaluation in this paper Paper-specific evaluated pipeline; exact checkpoint not inferred from label Individual claims | Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features Table 1., row ESM Only, column Val Accuracy; XML row3 column2 Version: preprint version in PMC | source checked automated source review · 2026-09-17 Audit detailsPrimary-source transcription and separate automated review. No human sign-off or experimental reproduction. Field: Source artifact SHA-256: Hash scope: Exact retrieved primary paper artifact bytes. |
| Introduction ESM Only as evaluated in the cited study. Paper-specific evaluated pipeline; exact checkpoint not inferred from label Individual claims | Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features Table 1., row ESM Only, column Val Accuracy; XML row3 column2 Version: preprint version in PMC | source checked automated source review · 2026-09-17 Audit detailsPrimary-source transcription and separate automated review. No human sign-off or experimental reproduction. Field: Source artifact SHA-256: Hash scope: Exact retrieved primary paper artifact bytes. |
View linked audit checks and correction history
Release 2026-09-29-06401fd5b220 · Record review: needs review
Stable ID: paper-model-d637ae639d81cd6303